DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China · Delayed Price · Currency is CNY 19.90
+0.32 (1.63%)
Jan 22, 2026, 3:00 PM CST
SHA:603233 Revenue
DaShenLin Pharmaceutical Group had revenue of 6.55B CNY in the quarter ending September 30, 2025, with 2.51% growth. This brings the company's revenue in the last twelve months to 26.83B, up 1.11% year-over-year. In the year 2024, DaShenLin Pharmaceutical Group had annual revenue of 26.50B with 8.01% growth.
Revenue (ttm)
26.83B
Revenue Growth
+1.11%
P/S Ratio
0.84
Revenue / Employee
616.42K
Employees
43,532
Market Cap
22.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.50B | 1.97B | 8.01% |
| Dec 31, 2023 | 24.53B | 3.28B | 15.45% |
| Dec 31, 2022 | 21.25B | 4.49B | 26.78% |
| Dec 31, 2021 | 16.76B | 2.18B | 14.92% |
| Dec 31, 2020 | 14.58B | 3.44B | 30.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.88B |
| Huadong Medicine | 43.09B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |